Tag: revascularisation
Studies highlight need for tailored treatment options for women with peripheral...
New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral arterial disease (PAD), including endovascular therapy and...
Paclitaxel controversy: Yes, device restrictions did cause harm
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Beth Israel Deaconess Medical Center, Boston, USA) during...
LUMIFOLLOW one-year outcomes show efficacy for femoropopliteal lesions
Luminor (iVascular) drug-coated balloon (DCB) has confirmed its excellent safety and efficacy in femoropopliteal lesions with new study LUMIFOLLOW, a recent press release states.
iVascular...
New analysis of chronic limb-threatening ischaemia patients places BEST-CLI trial into...
A new analysis of chronic limb-threatening ischaemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography &...
BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Data from new VOYAGER PAD reinforce benefit of XARELTO (rivaroxaban) plus...
An analysis showed benefit of XARELTO plus aspirin in reducing thrombotic hospitalisations for peripheral arterial disease (PAD) patients with and without chronic kidney disease...
Novel system-wide interdisciplinary team diverts patients from amputation and improves outcomes
Findings from a first-of-its-kind study conducted at University Hospitals (UH) Harrington Heart & Vascular Institute (Cleveland, USA) showed a novel system-wide interdisciplinary team assembled...
Study confirms efficiency of Upstream Peripheral’s GoBack catheter for complex lower...
Upstream Peripheral Technologies announced today that its GoBack catheter for crossing and re-entry was proven very effective for patients undergoing complex revascularisations in lower...
VOYAGER PAD subanalysis highlights risks for claudicants undergoing revascularisation
Principal investigator of the VOYAGER PAD trial, Marc Bonaca (University of Colorado Anschutz Medical Campus, Aurora, USA) speaks to Vascular News about the latest data...
Hispanic adults with PAD access inpatient care most often via the...
Hispanic adults hospitalised for treatment of symptoms of peripheral arterial disease (PAD) were more likely to access this care by going to the emergency...
Systematic review and meta-analysis finds “substantial” one-year mortality rate in octogenarians...
In octogenarians with chronic limb-threatening ischaemia (CLTI), researchers found a one-year mortality rate of 32% after revascularisation, which was significantly higher than in non-octogenarians....
Veterans study suggests surgery is still dominant revascularisation approach for critical...
A review of data from Veteran Health Administration shows that there was a temporal increase in the use of revascularisations for the management of...
Customising therapy in femoropopliteal revascularisation
Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based therapies have become a mainstay in femoropopliteal revascularisation and how interventionalists...
Oxygen monitoring predicts wound healing in critical limb ischaemia patients after...
Preliminary findings from an initial study with 25 patients have shown that measuring the changes in oxygen concentration at baseline, during, and after endovascular...
LINC 2018 data highlight IN.PACT Admiral as safe and effective treatment...
Medtronic added to its robust body of clinical evidence supporting the IN.PACT Admiral drug-coated balloon with new presentations that demonstrated durable and consistent clinical...
Medtronic gets US FDA clearance for Riptide aspiration system
The Riptide aspiration system is intended for use in the revascularisation of patients with acute ischaemic stroke secondary to intracranial large vessel occlusive disease...
More than one in six patients with PAD who undergo revascularisation...
A study of nearly 62,000 hospitalisations nationwide in the USA has found that more than one in six patients with peripheral arterial disease (PAD)...
ASTER trial finds “no increased rate of revascularisation” with stent retriever...
The ASTER randomised clinical trial that examined the effect of endovascular contact aspiration vs. stent retriever on revascularisation in patients with acute ischaemic stroke...
DANCE data boost for dexamethasone use after revascularisation in femoropopliteal arteries
While drug-eluting devices, be they balloons or stents, use chemotherapeutic agents (usually paclitaxel) to reduce the build-up of scar tissue inside the arteries, a...
